Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 15, 2026
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia.
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia.
Journal: American journal of hematology
Published: January 05, 2026
Pacritinib in patients with myelodysplastic/myeloproliferative neoplasms.
Journal: Leukemia & lymphoma
Published: November 26, 2025
Leukemia cutis and all-trans retinoic acid-induced myocarditis in acute promyelocytic leukemia.
Journal: Clinical hematology international
Published: November 11, 2025
Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm Development.
Journal: Current hematologic malignancy reports
Published: October 22, 2025
Ziftomenib in Relapsed or Refractory NPM1-Mutated AML.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 25, 2025
Combining drugs that bypass p53 to treat TP53-mutated leukemias.
Journal: Blood advances
Published: March 31, 2025
Allo-SCT in relapsed CBF-AML: rethinking the remission requirement.
Journal: Bone marrow transplantation
Published: March 14, 2025
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study.
Journal: JMIR cancer
Published: October 28, 2024
Case report: Isolated oligometastatic disease of the prostate from a primary lung adenocarcinoma.
Journal: Frontiers in oncology
Published: March 01, 2024
Last Updated: 09/26/2026